Abbott (NYSE: ABT) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.27 billion.

GUIDANCE:

Abbott sees FY2016 EPS of $2.10-$2.20, versus the consensus of $2.26.

For earnings history and earnings-related data on Abbott (ABT) click here.